Receive our newsletter – data, insights and analysis delivered to you
September 5, 2011

Orthocon to develop Bezwada technology

Orthocon, a manufacturer of products that stop bone bleeding, has entered into a worldwide licence agreement to develop and commercialise Bezwada Biomedical's technology for bone applications. Bezwada's proprietary technology platforms are comprised of bioabsorbable and biocompatible po

By cms admin

Orthocon, a manufacturer of products that stop bone bleeding, has entered into a worldwide licence agreement to develop and commercialise Bezwada Biomedical’s technology for bone applications.

Bezwada’s proprietary technology platforms are comprised of bioabsorbable and biocompatible polyurethanes, and polyamides derived from hydrolysable isocyanates.

The technologies can be used to create absorbable surgical devices for a variety of applications, including structural support, fixation and drug delivery.

Orthocon president and CEO John Pacifico said the strategic partnership is an important milestone for the company as it enhances the company’s technological capabilities and product pipeline.

The company has recently initiated development programmes to advance the Bezwada technology towards commercialisation, Orthocon said.

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
The powerful networks advancing life sciences in Charleston | USA
The power of infrastructure: How Charleston | SC | USA is expanding horizons for life science companies
Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU